Advancements in Intranasal Drug Delivery: Hovio...

By João L. Carapinha

May 15, 2026

Hovione and IDC have announced that their Intranasal Drug Delivery platform has advanced to commercial readiness, with the lead single-use nasal dry powder device now available for partnerships. This integrated solution combines API development, p...
Portugal Cannabis Market Decline: Analyzing the Impact of Licensing Reductions
Boosting Africa Vaccine Manufacturing: A New Era of Local Production and Supp...
NICE Approves Durvalumab for Gastric Cancer Treatment
Bladder Cancer Treatment Impact: Barriers to Quality of Life in Patients
Global Growth and Challenges in Pharmacy Vaccination Training
Key Strategies in Neonatal Infection Management: Insights from NICE Guideline...
Merck Oncology Advancements Highlight Long-Term Data and Pipeline Progress at...
Strengthening Supply Chains: The EU Critical Medicines Act
Johnson & Johnson Advances Neuropsychiatry Treatment Innovations at APA ...
Marstacimab Cost-Effectiveness Analysis in Hemophilia Treatment: A Portuguese...
Overcoming Challenges in Managed Entry Agreements for ATMPs
Breakthrough in Biocatalysis: Advancing Oral PCSK9 Inhibitors